An observational study of pro- and anti-angiogenic factors in hypertensive disorders of pregnancy in women of African ancestry

References

• Agrawal S, Shinar S, Cerdeira AS, Redman C, Vatish M. 2019. Predictive performance of PlGF (Placental Growth Factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis. Hypertension 74:1124–1135.
   PubMed Web of Science ®Google Scholar
• Atakul T. 2019. Serum levels of angiogenic factors distinguish between women with preeclampsia and normotensive pregnant women but not severity of preeclampsia in an obstetric center in Turkey. Medical Science Monitor 25:6924–6931.
   Web of Science ®Google Scholar
• Belovic DK, Plešinac S, Dotlić J, Radojević AS, Akšam S, Cvjetićanin MM, Kocijančić A. 2019. Biochemical markers for prediction of hypertensive disorders of pregnancy. Journal of Medical Biochemistry 38:71–82.
   PubMed Web of Science ®Google Scholar
• Brown MA, Magee LA, Kenny LC, Karumanchi SA, Mccarthy FP, Saito S, International Society for the Study of Hypertension in Pregnancy (ISSHP), et al. 2018. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension (Dallas, Tex. : 1979) 72:24–43.
   PubMed Web of Science ®Google Scholar
• Christians JK, Beristain AG. 2016. ADAM12 and PAPP-A: Candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblasts. Cell Adhesion & Migration 10:147–153.
   PubMed Web of Science ®Google Scholar
• De Villiers CP, Hedley PL, Placing S, Wøjdemann KR, Shalmi A-C, Carlsen AL, et al. 2017. Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia. Clinical Chemistry and Laboratory Medicine (CCLM) 56:65–74.
   Google Scholar
• Eddy AC, Bidwell GL, George EM. 2018. Pro-angiogenic therapeutics for preeclampsia. Biology of Sex Differences 9:36.
   PubMed Web of Science ®Google Scholar
• Flint EJ, Cerdeira AS, Redman CW, Vatish M. 2019. The role of angiogenic factors in the management of preeclampsia. Acta Obstetricia et Gynecologica Scandinavica 98:700–707.
   PubMed Web of Science ®Google Scholar
• Gadde R, Dayanand CD, Sheela SR. 2018. Placental protein 13: An important biological protein in preeclampsia. Journal of Circulating Biomarkers 7:1849454418786159.
   Google Scholar
• Gathiram P, Moodley J. 2016. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovascular Journal of Africa 27:71–78.
   PubMed Web of Science ®Google Scholar
• Gökdemir İE, Evliyaoğlu Ö, Çoşkun B. 2016. The role of ADAMTS genes in preeclampsia. Turkish Journal of Obstetrics and Gynecology 13:149–153.
   PubMedGoogle Scholar
• Kalousova M, Muravska A, Zima T. 2014. Pregnancy-associated plasma protein A (PAPP-A) and preeclampsia. Advances in Clinical Chemistry. 63:169–209.
   Google Scholar
• Karumanchi SA. 2016. Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension 67:1072–1079.
   PubMed Web of Science ®Google Scholar
• Kirbas A, Daglar K, Timur H, Yilmaz Z, Gencosmanoglu G, Danisman N. 2016. Circulating ADAMTS-12 levels in early-and late-onset severe preeclampsia. Medicine Science 5:785–789.
   Google Scholar
• Luewan S, Teja-Intr M, Sirichotiyakul S, Tongsong T. 2018. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia. Singapore Medical Journal 59:55–59.
   PubMed Web of Science ®Google Scholar
• Meazaw MW, Chojenta C, Muluneh MD, Loxton D. 2020. Factors associated with hypertensive disorders of pregnancy in sub-Saharan Africa: A systematic and meta-analysis. PloS One 15:e0237476.
   PubMed Web of Science ®Google Scholar
• Mchunu N, Pillay P, Moodley J, Mackraj I. 2018. Circulatory levels of tumor necrosis factor-α, interleukin-6, and syncytiotrophoblast microvesicles in the first trimester of pregnancy. Clinical and Experimental Obstetrics & Gynecology 45:575–581.
   Web of Science ®Google Scholar
• Moodley J, Soma-Pillay P, Buchmann E, Pattinson RC. 2019. Hypertensive disorders in pregnancy: 2019 national guideline. South African Medical Journal 109:12723.
   PubMedGoogle Scholar
• NICE. Hypertension in pregnancy: diagnosis and management. NICE Guideline 2019.
   Google Scholar
• Nikuei P, Davoodian N, Tahamtan I, Keshtkar AA. 2016. Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocol. BMJ Open 6:e011920.
   PubMed Web of Science ®Google Scholar
• Pillay P, Moodley K, Moodley J, Mackraj I. 2017. Placenta-derived exosomes: potential biomarkers of preeclampsia. International Journal of Nanomedicine 12:8009–8023.
   PubMed Web of Science ®Google Scholar
• Pillay P, Moodley K, Vatish M, Moodley J. 2020. Exosomal MicroRNAs in Pregnancy Provides Insight into a Possible Cure for Cancer. International Journal of Molecular Sciences 21:5384.
   PubMed Web of Science ®Google Scholar
• Sammar M, Drobnjak T, Mandala M, Gizurarson S, Huppertz B, Meiri H. 2019. Galectin 13 (PP13) facilitates remodeling and structural stabilization of maternal vessels during pregnancy. International Journal of Molecular Sciences 20:3192.
   PubMed Web of Science ®Google Scholar
• Sava RI, March KL, Pepine CJ. 2018. Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice. Clinical Cardiology 41:220–227.
   PubMed Web of Science ®Google Scholar
• Saxena AR, Seely EW, Rich-Edwards JW, Wilkins-Haug LE, Karumanchi SA, Mcelrath TF. 2013. First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia. BMC Pregnancy and Childbirth 13:85.
   PubMed Web of Science ®Google Scholar
• Shen M, Smith GN, Rodger M, White RR, Walker MC, Wen SW. 2017. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PloS One 12:e0175914.
   PubMed Web of Science ®Google Scholar
• Tannetta D, Sargent I. 2013. Placental disease and the maternal syndrome of preeclampsia: missing links? Current Hypertension Reports 15:590–599.
   PubMed Web of Science ®Google Scholar
• Veisani Y, Jenabi E, Delpisheh A, Khazaei S. 2019. Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis. International Journal of Reproductive BioMedicine 17:1.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou Y, Wu Q, Fan W, Ye J, Chen Y, et al. 2017. Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1. Experimental and Therapeutic Medicine 14:391–397.
   PubMed Web of Science ®Google Scholar